Something has changed in the ketamine therapy landscape over the last few years, and we think patients deserve an honest conversation about it.
At-home ketamine kits — compounded oral troches, lozenges, and nasal sprays prescribed through telehealth platforms and mailed directly to patients — have become widely available and aggressively marketed. The price point is appealing. The convenience is real. And for patients who have been suffering and can’t afford in-clinic care, the appeal makes complete sense to us.
But a growing body of evidence — from the FDA, from peer-reviewed research, and from investigative journalism — is raising serious questions about whether at-home ketamine is as safe as it’s being presented. We’re not writing this to scare anyone, and we’re not writing it to bash competitors. We’re writing it because we think people considering ketamine therapy deserve to make an informed decision, and right now, not all of the information is reaching them.
What the FDA Has Actually Said
The FDA has issued formal warnings about compounded ketamine products on multiple occasions. In February 2022, it published a risk alert about compounded ketamine nasal spray used at home, citing psychiatric adverse events including delusion, dissociation, visual hallucination, and panic attack reported in patients who self-administered the product without clinical monitoring.
In October 2023, the FDA issued a broader warning covering oral and sublingual formulations — the kind most commonly mailed to patients through telehealth platforms. The agency stated directly: “Use of compounded ketamine products without monitoring by a health care provider for sedation, dissociation, and changes in vital signs may put patients at risk for serious adverse events.”
The FDA also noted that compounded ketamine products are not FDA-approved, meaning the agency has not evaluated their safety, effectiveness, or quality prior to marketing. Known safety concerns the FDA identified include abuse and misuse, psychiatric events, increases in blood pressure, respiratory depression, and lower urinary tract and bladder symptoms.
This isn’t a technicality. These are formal public health warnings from the agency responsible for drug safety in the United States, issued twice in two years because the first warning didn’t change the trajectory of at-home prescribing.
What Happened When a Journalist Looked Closely
In March 2026, STAT News published an investigation by a writer who had achieved remission from treatment-resistant depression using supervised esketamine — and then, when insurance denied continued coverage, turned to Reddit to research at-home alternatives.
What he found alarmed him enough to abandon his plans and write about it publicly.
He analyzed six months of posts and comments from r/TherapeuticKetamine and r/KetamineTherapy — two Reddit communities where at-home ketamine patients gather. He found patients comparing contradictory instructions from their telehealth providers and managing serious side effects using Reddit upvotes as clinical guidance. His conclusion was direct: telehealth ketamine platforms have turned patients into their own safety monitors, forcing them to navigate a medical situation from their bedrooms that requires real clinical judgment.
A peer-reviewed study published in the journal Behavioral Sciences in March 2026 analyzed 500 of the highest-engagement threads from r/TherapeuticKetamine — representing 12,852 comments. Researchers found that 70% of reported doses exceeded 149mg, suggesting a trend toward higher-dose self-administration. They noted that ketamine’s dissociative properties may actually impair patients’ ability to recognize when something is going wrong — meaning the people most in need of monitoring are the least equipped to monitor themselves.
What “No Real-Time Monitoring” Actually Means
This phrase keeps appearing in the FDA warnings, the research, and the journalism. It’s worth being concrete about what it means in practice.
When a patient takes ketamine — in any form — it causes dissociation: a disconnection between thoughts, feelings, and sense of time and space. Blood pressure rises, sometimes significantly. Heart rate changes. Breathing can slow. In a clinical setting, a physician monitors vital signs in real time throughout the session and can intervene immediately if anything goes wrong. The dose can be adjusted. Medications to manage side effects can be administered on the spot.
At home, none of that is available. If a patient’s blood pressure spikes, they may not know it. If their breathing slows, they may be too dissociated to notice. If they experience a severe psychiatric reaction — hallucinations, panic, delirium — their options are to call 911, text a Reddit community, or wait it out alone.
The FDA reported one case of a patient who took compounded oral ketamine at home for PTSD and experienced slowed breathing and reached a ketamine blood level approximately twice what would typically be administered as anesthesia. This was reported as a formal adverse event.
Why We’re Telling You This
We want to be clear about what we are not saying.
We are not saying that every at-home ketamine experience is dangerous. Many people use these services without incident. We are not saying telehealth has no role in mental health care — it has expanded access in meaningful ways. And we are not saying cost is an irrelevant consideration. We know IV ketamine is not cheap, and we know the price difference between an in-clinic series and a telehealth subscription is real.
What we are saying is this: ketamine is a powerful dissociative anesthetic that changes your blood pressure, your heart rate, your breathing, and your perception of reality. The question of whether it should be self-administered at home, without real-time clinical oversight, is not a trivial one. And the evidence that has accumulated — from the FDA, from peer-reviewed research, and from investigative journalism — suggests the answer carries more risk than the marketing materials acknowledge.
At AlphaOmega Wellness, every infusion is administered intravenously by Dr. Dee Bonney, MD — a board-certified emergency medicine physician with 25+ years of experience. Your vital signs are monitored continuously throughout the session. Megan Bonney, PMHNP-BC, provides clinical context before and after each infusion. You are never alone, and you are never your own safety monitor.
That’s not a marketing point. It’s the standard of care that ketamine requires.
The Access Problem Is Real — And Worth Solving Differently
We understand that cost is often what drives patients toward at-home alternatives. At AlphaOmega Wellness we accept HSA and FSA payments, offer flexible financing, and provide discounts for first responders and veterans. We’re happy to talk through options during a free consultation — no pressure, no obligation. If in-clinic IV ketamine isn’t feasible for someone financially, we’d rather be honest about that than watch them make a decision without full information.
What to Ask Any Ketamine Provider Before You Start
Whether you’re considering AlphaOmega Wellness, another in-clinic provider, or a telehealth platform, here are the questions that matter:
- Who will be monitoring me during treatment, and what are their qualifications? Is it a physician? A nurse? No one?
- What happens if I have an adverse reaction? Is someone present who can intervene, or am I expected to call 911?
- How is the dose determined and adjusted? Is it individualized by a physician who knows my history, or is it a standard dose selected from a menu?
- Is this compounded ketamine or pharmaceutical-grade IV ketamine? These are meaningfully different products.
- Has this provider been subject to any regulatory action? The DEA and state medical boards have taken action against several telehealth ketamine platforms in recent years.
You deserve honest answers to all of these questions before you take a powerful dissociative anesthetic — regardless of which provider you choose.
Frequently Asked Questions
What is compounded ketamine and how is it different from IV ketamine?
Compounded ketamine is ketamine prepared by a compounding pharmacy — often reformulated into an oral lozenge, sublingual troche, or nasal spray at a custom dose. It is not FDA-approved, meaning the FDA has not evaluated its safety, effectiveness, or quality. IV ketamine uses pharmaceutical-grade ketamine administered intravenously in a clinical setting by a physician. IV ketamine reaches the bloodstream with close to 100% bioavailability; oral and sublingual forms have significantly lower and less predictable absorption.
Is at-home ketamine illegal?
Not currently. The DEA extended Covid-era telemedicine flexibilities through December 31, 2026, allowing providers to prescribe Schedule III controlled substances like ketamine without an in-person visit. However, legal availability and clinical safety are separate questions. The FDA has issued formal warnings about the safety risks of compounded ketamine used at home regardless of its legal status.
What does the FDA say about at-home ketamine specifically?
The FDA has issued two formal warnings — in February 2022 and October 2023 — about compounded ketamine products used at home. The agency specifically warns that use without real-time monitoring by a health care provider for sedation, dissociation, and changes in vital signs may put patients at risk for serious adverse events. Known concerns include abuse and misuse, psychiatric events, blood pressure increases, respiratory depression, and bladder symptoms.
Why does monitoring matter so much with ketamine?
Ketamine causes dissociation — a disconnection from your thoughts, feelings, and sense of reality. This is part of how it works therapeutically, but it also means you may not be able to accurately perceive or respond to your own physiological state during treatment. Blood pressure rises with ketamine. Breathing can slow. If something goes wrong, the dissociative state itself can impair your ability to recognize it. Real-time monitoring by a qualified clinician exists specifically to catch and respond to these changes before they become dangerous.
Can telehealth ketamine work safely for anyone?
This is a question researchers and regulators are actively debating. Some argue that low-dose oral ketamine under careful telehealth supervision may be appropriate for certain lower-risk patients. What the evidence clearly supports is that higher-dose ketamine — particularly IV — requires in-person clinical monitoring. At AlphaOmega Wellness, we believe the therapeutic benefit of IV ketamine is closely tied to the safety and individualization that in-clinic care provides.
How do I know if a ketamine provider is reputable?
Key markers include physician oversight during every session, real-time vital sign monitoring, individualized dosing based on your medical history, pharmaceutical-grade IV ketamine, a formal intake and screening process, and integration support. Ask specifically who will be in the room during your infusion and what their credentials are. At AlphaOmega Wellness, every infusion is conducted under the medical direction of Dr. Dee Bonney, MD, a board-certified emergency physician with 25+ years of experience — with ACLS-certified clinical staff present at all times.
Is IV ketamine at AlphaOmega Wellness safe?
IV ketamine administered in a physician-supervised clinical setting has a well-established safety profile when used at appropriate doses with proper monitoring. At AlphaOmega Wellness, we have completed more than 5,000 infusions. Every session is supervised by Dr. Dee Bonney, MD, with continuous vital sign monitoring throughout. Side effects — most commonly temporary dissociation, nausea, and blood pressure changes — occur within a monitored clinical environment where our team can respond immediately.
What if I can’t afford in-clinic IV ketamine?
We understand cost is a real barrier for many patients. At AlphaOmega Wellness we accept HSA and FSA payments, offer flexible financing, and provide discounts for first responders and veterans. We encourage anyone who is curious to start with a free consultation — we’ll be honest about what’s feasible for your situation. Book a free consult here or call us at 317-300-4091.
Sources: FDA compounding risk alerts (February 2022, October 2023) via fda.gov; STAT News, March 2, 2026; Behavioral Sciences, “Ketamine Use in Self-Described Therapeutic Contexts: A Thematic Analysis of Reddit Posts,” PMC, March 2026; Psychiatric Times, “Ketamine Safety in 2026,” June 2026; PharmExec, “Ketamine’s Regulatory Reckoning,” June 2026.